Wade Grindle MD

FDA Approval Expected Monday of Ketamine-derived “Spravato”

      TAKE HOME POINTS: SpravatoTM, a form of ketamine, will be FDA approved on Monday for Treatment Resistant Depression and for Major Depression with suicidality. FDA approval will result in insurance coverage for this form of ketamine, for this purpose, which will make it affordable for millions of suffering patients. Although it is...

MORE

New Psychology Today article on Ketamine

The current edition of Psychology Today has a (mostly accurate) article about the revolutionary success ketamine has in treating depression and PTSD. We applaud their raising public awareness about the fact that ketamine removes suicidality within hours, and that it works overall in about 70 percent of patients who have not gotten adequate relief from...

MORE

Popular Blog Posts

Ketamine Infusion Therapy for PTSD – Results of an Important New Study

Ketamine – The Most Powerful Treatment For Depression Yet Invented

Ketamine continues to gain recognition, by both lay public and medical professionals, as a remarkably effective antidepressant, with minimal…

LEARN MORE

Coronavirus Anxiety Syndrome

Many of our ketamine therapy patients tell us that the COVID-19 pandemic is causing a dramatic increase in their…

LEARN MORE

FDA Approval Expected Monday of Ketamine-derived “Spravato”

      TAKE HOME POINTS: SpravatoTM, a form of ketamine, will be FDA approved on Monday for Treatment…

LEARN MORE

End The Stigma!

Lady Gaga and Bradley Cooper did a masterful remake of “A Star is Born”, now in theaters. We highly…

LEARN MORE

New Psychology Today article on Ketamine

The current edition of Psychology Today has a (mostly accurate) article about the revolutionary success ketamine has in treating…

LEARN MORE